LncRNA-mediated Modulation of Endothelial Cells: Novel Progress in the Pathogenesis of Coronary Atherosclerotic Disease

Curr Med Chem. 2024;31(10):1251-1264. doi: 10.2174/0929867330666230213100732.

Abstract

Coronary atherosclerotic disease (CAD) is a common cardiovascular disease and an important cause of death. Moreover, endothelial cells (ECs) injury is an early pathophysiological feature of CAD, and long noncoding RNAs (lncRNAs) can modulate gene expression. Recent studies have shown that lncRNAs are involved in the pathogenesis of CAD, especially by regulating ECs. In this review, we summarize the novel progress of lncRNA-modulated ECs in the pathogenesis of CAD, including ECs proliferation, migration, adhesion, angiogenesis, inflammation, apoptosis, autophagy, and pyroptosis. Thus, as lncRNAs regulate ECs in CAD, lncRNAs will provide ideal and novel targets for the diagnosis and drug therapy of CAD.

Keywords: Long noncoding RNAs; coronary atherosclerotic heart disease; diagnosis; drug therapy; endothelial cells; smooth muscle cell..

Publication types

  • Review

MeSH terms

  • Atherosclerosis* / metabolism
  • Cardiovascular Diseases* / metabolism
  • Coronary Artery Disease* / genetics
  • Coronary Artery Disease* / pathology
  • Endothelial Cells / metabolism
  • Humans
  • RNA, Long Noncoding* / genetics
  • RNA, Long Noncoding* / metabolism

Substances

  • RNA, Long Noncoding